2013 Publications

Abu Kwaik, Y., Bumann, D. 2013. Microbial Quest for Food in vivo: “Nutritional virulence” as an emerging paradigm.
Cell.Microbiol., 15, 882–890.

Abu Kwaik, Y. 2013. Targeting nutrient retrieval by Francisella tularensis. Front.Cell.Infect.Microbiol., 3:64. doi:10.3389/fcimb.2013.00064.

Adedeji, A.O., Severson, W., Jonsson, C., Singh, K. Weiss, S.R., Sarafianos, S.G. 2013. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J. Virol. 87: 8017-28.

Bagci U, Foster B, Miller-Jaster K, Luna B, Dey B, Bishai WR, Jonsson CB, Jain S, Mollura DJ (2013) A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging. EJNMMI Res. 2013 3:55

Bruckert, W.M., Price, C.T., Abu Kwaik, Y. 2013. Rapid Nutritional Remodeling of the Host Cell Upon Attachment of Legionella pneumophila. Infect.Immun. In Press.

Camp, J.V., Chu, Y-K, Chung, D., McAllister, R., Gerlach, R.L., Adcock, R.S., Wiemken, T.L., Peyrani, P., Ramirez, J., Summersgill, J.T., Jonsson, C.B. (2013) Phenotypic Differences in Virulence and Immune Response in Closely Related Clinical Isolates of Influenza A 2009 H1N1 Pandemic Viruses in Mice. PLoS ONE. 8: e56602. PMID: 23441208

Chung, D. H.; Moore, B. P.; Matharu, D. S.; Golden, J. E.; Maddox, C.; Rasmussen, L.; Sosa, M. I.; Ananthan, S.; White, E. L.; Jia, F.; Jonsson, C. B.; Severson, W. E.. 2013. A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus. Virology journal, 19.

Chung, D. H.; Vastermark, A.; Camp, J. V.; McAllister, R.; Remold, S. K.; Chu, Y. K.; Bruder, C.; Jonsson, C. B. 2013. The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment. Journal of virology, (20), 10997-1007.

Eng, M., Jones, C.M., Hughes, M.G., Davis, E., Marvin, M.R. 2013. The presence of polyomavirus BK replication in urine or plasma correlate with significant renal impairment in renal transplant recipients. Abstract #C1370. American Journal of Transplantation, 13(Suppl 5):435.

Gerlach, R.L., Camp, J.V., Chu, Y., and Jonsson, C.B. (2013) Early Host Responses of Seasonal and Pandemic Influenza A Viruses in Primary Human Lung Epithelial Cells. PLoS ONE 8:e78912. PMID: 24244384

Guo, H,., Miao, Y. 2013. Design and Evaluation of New Tc-99m-Labeled Lactam Bridge-Cyclized Alpha-MSH Peptides for Melanoma Targeting. Molecular Pharmaceutics 10:1400-8.

Guo, H., Hathaway, H., Royce, M.E., Prossnitz, E.R., Miao, Y. 2013. Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides. Bioorganic & Medicinal Chemistry Letters, 23:5484-7.

Guo, H., Miao, Y. 2013. Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide. Bioorganic & Medicinal Chemistry Letters, 23:2319-23.

Hughes, M.G., Reddy, S.C., Brier, M., McClain, C.J., Jonsson, C.B. 2013. Is micro-RNA-122 (miR-122) an accurate biomarker for ischemia-reperfusion injury during liver transplantation? Abstract #B1146. American Journal of Transplantation, 13(Suppl 5):370.

Jonsson , C.B. Cole, K.S., Perlin, D.S., Roy, C.J., and RBL Director Network. (2013) Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents. J Bioterr Biodef S3:015. doi: 10.4172/2157-2526.

Lawrenz, M.B., J.M. Pennington, and V.L. Miller. 2013. Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis. Mol. Microbiol., doi: 10.1111/mmi.12273. PMID: 23701256.

Lukashevich IS (2013). The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines. 2013 Jan;12(1):71-86. doi: 10.1586/erv.12.139.

Martin, D.T., Steinbach, J.M., Liu, J., Shimizu, S., Kaimakliotis, H.Z., Wheeler, M.A., Hittelman, A.B., Saltzman, W.M., Weiss, R.M. 2013. Surface modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer. Molecular Cancer Therapeutics. (Accepted: Nov. 2013).

Ogg, M., Jonsson, C.B. Camp, J.V., and Hooper J.W. (2013) Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus. Viruses 5:2704-20. PMID: 24217424

Price, C. T., Abu Kwaik, Y. 2013. One bacterial effector with two distinct catalytic activities by different strains. EMBO Reports, DOI:10.1038/embor.2013.126. In Press.

Price, C.T., Richards, A. M. Von Dwingelo, J. E., Samara, H. A., Abu Kwaik, Y. 2013. Legionella pneumophila synchronization of amino acid auxotrophy and its role in adaptation and pathogenic evolution to the amoeba host. Environ. Microbiol., 14:759-764, doi:10.1038/embor.2013.116.

Richards, A.M., von Dwingelo, J.E., Price, C.T., Abu Kwaik, Y. 2013. Cellular Microbiology and Molecular Ecology of Legionella-Amoeba Interaction. Virulence, 4:1-8.

Scott JB, Fodah RA, Tam H, Yan P, Pfeffer TL, Bundschuh R, Warawa JM. 2014. Correlation of Klebsiella pneumoniae comparative genetic analyses with virulence profiles in a murine respiratory disease model. PLoS One. 2014. Accepted with corrections.

Steinbach, J.M. and Caplan, M.R. 2013. In vitro validation of targeting and comparison to mathematical modeling. Methods in Molecular Biology: Targeted Drug Delivery. Book chapter. (Submitted: 10/27/13).

Tretyakova I, Igor S. Lukashevich, Pamela Glass, Eryu Wang, Scott Weaver, Peter Pushko (2013). Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine, 31:1019-1025.

Warawa J.M., M.B. Lawrenz M.B.. 2014. Bioluminescent imaging of bacteria during mouse infection. Bioluminescent Imaging. Methods Mol. Biol., 1098:169-81. PMID: 24166377

Zapata JC, Carrion R Jr, Patterson JL, Crasta O, Zhang Y, Mani S, Jett M, Poonia B, Djavani M, David M. White DM, Lukashevich IS, Salvato MS (2013). Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Reassortant ML29, a Vaccine Candidate. PLoS Negl Trop Dis 7(9): e2406; doi:101371/journal.pntd.0002406.

Zapata, J.C., M. Goicochea, Y. Nadai, L. Eyzaguirre, J. Carr, L.J. Tallon, L. Sadzewicz, G. Myers, C. Fraser-Liggett, M. Djavani, I.S. Lukashevich, M.S. Salvato (2013) Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. J. Virol., in press

Zapata JC, Poonia B, Bryant J, Davis H, Ateh E, George L, Crasta O, Zhang Y, Slezak T, Jaing C, Pauza CD, Goicochea M, Moshkoff D, Lukashevich IS (2013). An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. Virology J, Feb 12;10(1):52